CLOVERNA, Inc.
- Biotech or pharma, therapeutic R&D
- Biotech or pharma, animal health
CLOVERNA is pioneering RNA-targeted therapies to revolutionize RNA drug discovery by exploring uncharted non-coding RNA regions. Our lead programs, CLV-301 for malignant ascites and CLV-201 for ALS, target critical unmet medical needs.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}